Who is desvenlafaxine for and who needs to take extra care?
Who is desvenlafaxine for?
Desvenlafaxine is used to treat adults with depression.
People who should take extra care with desvenlafaxine
Make sure you tell your doctor if you have, or have had in the past, any of the following conditions (you might need to take extra precautions, or another medicine might be more suitable):
- bipolar disorder
- epilepsy, a history of fits (seizures)
- a tendency to bleed more than normal or you are taking a blood thinning medicine
- kidney or liver problems
- high blood pressure
- raised cholesterol or lipid levels
- heart problems
- low blood sodium.
Get advice, either directly from your doctor or from a specialist information line, about the risks of taking antidepressants if you are pregnant, breastfeeding or thinking about becoming pregnant. See Antidepressants, pregnancy and breastfeeding.
Your doctor may also advise caution or another medicine if you are 80 years of age or older, or are taking medicines that increase the risk of stomach bleeding (eg, aspirin or other nonsteroidal anti-inflammatory drugs [NSAIDs] such as ibuprofen).
Find out more about
- What desvenlafaxine does and how effective it is
- Side effects of desvenlafaxine
- Interactions with desvenlafaxine
- Brands of desvenlafaxine
If you are starting desvenlafaxine, see 10 things you should know about antidepressants.
For more information
- Starting, switching and stopping antidepressants
- Managing side effects of antidepressants
- Psychological therapies
The consumer medicine information (CMI) for your brand of desvenlafaxine is available from our website or a pharmacist. The CMI includes:
- how to take this medicine
- what to do if you forget to take it
- if you take too much (overdose)
- things you must and must not do while taking this medicine
- signs of severe reactions and what to do.
- Rossi S, ed. eAMH [online]. Adelaide: Australian Medicines Handbook, 2012. www.amh.net.au. (Accessed 9 February 2012).
- Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic, Version 6. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited; 2008.
- Pfizer Australia Pty Ltd. Pristiq consumer medicine information. 2 May 2011. (Accessed 22 March 2012).